Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Exact's colorectal cancer test in trial at Mayo Clinic

This article was originally published in Clinica

Executive Summary

The Mayo Clinic is to carry out a major prospective study of Exact Sciences' genomics-based colorectal cancer test with the support of a $4.9 million grant from the US National Cancer Institute. The test is based on analysis of DNA isolated from stool using the same sample processing technology as the PreGen-26 test launched at the end of May (see Clinica No 959, p 19).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT071870

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel